IDIBELL-Bellvitge Biomedical Research Institute

The Bellvitge Biomedical Research Institute (IDIBELL) was created in 2004. It is the foundation that manages the research activities of Bellvitge University Hospital, the Catalan Oncology Institute, the Bellvitge campus of the University of Barcelona, and the public health companies Institut de Diagnòstic per la Imatge (Image Diagnosis Institute) and Banc de Sang i Teixits (Blood and Tissue Bank). The Institute is the core of Biopol, the health research park of Hospitalet de Llobregat, in the South of Barcelona. The president of the IDIBELL’s managing board is the Catalan Minister of Health, Marina Geli. IDIBELL has more than 500 researchers and manages a budget of almost 22 million euros. The Foundation’s main scientific partners are the University of Barcelona, the Catalan Oncology Institute and the Catalan Health Institute (the managing company of the Bellvitge University Hospital). Since March 2009, it is one of the five research centers accredited by the Spanish Ministry of Health.

Some content from Wikipedia, licensed under CC BY-SA

Discovered a cause of mental retardation and autism

The term intellectual disability covers a large number of clinical entities, some with known cause and others of uncertain origin. For example Down syndrome is due to an extra copy of chromosome 21 and Rett syndrome is in ...

Jul 20, 2015
popularity29 comments 0

A new mouse model for the study of neurofibromatosis

The research group of the neurofibromatosis of the Catalan Institute of Oncology (ICO), the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Institute of Medicicina Predictive and Personalized Cancer (IMPPC) ...

Apr 16, 2015
popularity16 comments 0

When genes are expressed in reverse

Genes usually always be expressed as in Western writing: from left to right on the white canvas of our DNA. So when we speak of the activity of our genome, in fact we are referring to the expression of genes in this sense ...

Apr 21, 2015
popularity4 comments 0

New breast cancer classification based on epigenetics

Breast cancer is the most common in women. One in nine will suffer breast cancer over their lifetime. Progress in prevention and early detection, and the use of chemotherapy after surgery (adjuvant chemotherapy), have achieved ...

Dec 10, 2014
popularity0 comments 0